British Journal of HaematologyGenetic & Genomic MedicinePeer-reviewed journal article
A Sardinian founder mutation in GP1BB that impacts thrombocytopenia.
Fabio BusoneroiD, Maristella SteriiD, Valeria OrrùiD, Gabriella SoleiD, Stefania OllaiD, Michele MarongiuiD, Carlo SidoreiD, Sandra LaiiD, Antonella MulasiD, Andrea MaschioiD, Magdalena ŻołędziewskaiD, Matteo FlorisiD, Mauro PalaiD, Paola ForaboscoiD, Isadora AsunisiD, Maristella PitzalisiD, Francesca DeiddaiD, Marco MasalaiD, Cristian Antonio CariaiD, Susanna BarellaiD, Gonçalo R. AbecasisiD, David SchlessingeriD, Serena SannaiD, Edoardo FiorilloiD, Francesco CuccaiD
Abstract
To investigate the genetic regulation of platelet (PLT) levels we carried out a whole-genome association analysis in 6,528 Sardinians from the general population of the Lanusei valley. We found 6 variants significantly influencing PLT levels, including a novel rare missense mutation (p.Pro27Ser) in the GP1BB protein that is associated with PLT reduction (P=1.17x10-16). This mutation is rare in the SardiNIA population cohort (frequency of 0.45%), even rarer in the rest of the Sardinian island (frequency of 0.16%), and not reported elsewhere. Notably, GP1BB is involved in Bernard-Soulier syndrome (BSS), a rare autosomal recessive bleeding disorder caused by a defect in the platelet GPIb-IX-V protein complex. Consistently, the 57 identified individuals heterozygous for the p.P27S mutation showed mild thrombocytopenia, morphologically enlarged platelets (P=2.13x10-10), and reduced expression of two GPIb-IX-V-complex components: GPIb (-26.51%, P=3.66x10-8) and GPIX (-24.69%, P=2.66x10-6). Molecular modeling infers a corresponding reduction in the stability of GP1BB. These observations predict that in homozygosity as well as in individuals carrying specific compound heterozygous configurations, this variant likely causes BSS.
- organism: human
- assay: whole-genome sequencing
- research focus: differential expression
- approach: statistical model
- Citations
- 2
- FWCI
- 0.32
- Field percentile
- top 40%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Platelet findings in 22q11.2 Deletion Syndrome correlate with disease manifestations but do not correlate with GP1b surface expression
Ian M. Campbell, Terrence Blaine Crowley, … Michele P. Lambert·Clinical GeneticsPeer-reviewed·Sep 8, 2022
- Genomic Landscape of Patients with Germline RUNX1 Variants and Familial Platelet Disorder with Myeloid Malignancies in a Natural History Study
Kai Yu, Natalie T Deuitch, … Paul Liu·Blood AdvancesPeer-reviewed·Nov 29, 2023
- Role of the novel endoribonuclease SLFN14 and its disease causing mutations in ribosomal degradation
S. J. Fletcher, V. P. Pisareva, … A. V. Pisarev·bioRxiv·Feb 18, 2018
- PIK3R3 is a candidate regulator of platelet count in people of Bangladeshi ancestry
Kate Burley, Lucy Fitzgibbon, … Andrew David Mumford·Research and Practice in Thrombosis and HaemostasisPeer-reviewed·May 1, 2023
- Genome Sequencing Unveils a New Regulatory Landscape of Platelet Reactivity
Ali Reza Keramati, Ming‐Huei Chen, … Paul S. de Vries·Nature CommunicationsPeer-reviewed·Jun 15, 2021
- Gene mutations in members of the PI3K/Akt signalling pathway are related to immune thrombocytopenia pathogenesis